Volume 17, Number 12—December 2011
Research
A Pilot Study of Host Genetic Variants Associated with Influenza-associated Deaths among Children and Young Adults1
Table 2
Gene | Variant | Genotype | Genotype frequency, no. (%) case-patients |
|||
---|---|---|---|---|---|---|
All, n = 105 | White, n = 64 | Black, n = 18 | Asian, n = 7 | |||
TNF | rs1800629 | −308GG | 74 (70) | 47 (73) | 10 (56) | 6 (86) |
−308GA | 30 (29) | 16 (25) | 8 (44) | 1 (14) | ||
−308AA | 1 (1) | 1 (2) | 0 | 0 | ||
A allele | 0.152 | 0.141 | 0.222 | 0.071 | ||
rs1800750 | −555GG | 101 (96) | 62 (97) | 16 (89) | 7 (100) | |
−555GA | 4 (4) | 2 (3) | 2 (11) | 0 | ||
−555AA | 0 | 0 | 0 | 0 | ||
A allele | 0.019 | 0.016 | 0.056 | 0 | ||
rs361525 | −238GG | 95 (90) | 59 (92) | 14 (78) | 6 (86) | |
−238GA | 10 (10) | 5 (8) | 4 (22) | 1 (14) | ||
−238AA | 0 | 0 | 0 | 0 | ||
A allele |
0.048 |
0.039 |
0.111 |
0.071 |
||
MBL2 | rs1800450 (B variant) | 27GG | 77 (73) | 47 (73) | 15 (83) | 5 (71) |
27GA | 27 (26) | 17 (27) | 3 (17) | 2 (29) | ||
27AA | 1 (1) | 0 | 0 | 0 | ||
A allele | 0.138 | 0.133 | 0.083 | 0.143 | ||
rs1800451 (C variant)† | 18GG | 95 (90) | 61 (95) | 12 (67) | 7 (100) | |
18GA | 9 (9) | 3 (5) | 5 (28) | 0 | ||
18AA | 1 (1) | 0 | 1 (6) | 0 | ||
A allele | 0.052 | 0.023 | 0.194 | 0 | ||
rs5030737 (D variant) | 34CC | 95 (90) | 55 (86) | 17 (94) | 7 (100) | |
34CT | 9 (9) | 8 (13) | 1 (6) | 0 | ||
34TT | 1 (1) | 1 (2) | 0 | 0 | ||
T allele | 0.052 | 0.078 | 0.028 | 0 | ||
rs7096206 (X/Y variant) | −221CC | 71 (68) | 43 (67) | 14 (78) | 4 (57) | |
−221CG | 32 (30) | 20 (31) | 3 (17) | 3 (43) | ||
−221GG | 2 (2) | 1 (2) | 1 (6) | 0 | ||
G allele | 0.171 | 0.172 | 0.139 | 0.214 | ||
rs11003125 (H/L variant) | −550CC | 43 (41) | 21 (33) | 12 (67) | 2 (29) | |
−550CG | 46 (44) | 34 (53) | 6 (33) | 4 (57) | ||
−550GG | 16 (15) | 9 (14) | 0 | 1 (14) | ||
G allele | 0.371 | 0.406 | 0.167 | 0.429 | ||
Pooled structural variants | AA | 59 (56) | 37 (58) | 8 (44) | 5 (71) | |
AO | 41 (39) | 24 (38) | 9 (50) | 2 (29) | ||
OO | 5 (5) | 1 (2) | 1 (6) | 0 | ||
Truncated haplotypes | YA/YA | 36 (34) | 21 (33) | 5 (28) | 3 (43) | |
XA/YA | 21 (20) | 15 (23) | 2 (11) | 2 (29) | ||
XA/XA | 2 (2) | 1 (2) | 1 (6) | 0 | ||
YA/O | 30 (29) | 19 (30) | 8 (44) | 1 (14) | ||
XA/O | 11 (10) | 5 (8) | 1 (6) | 1 (14) | ||
O/O | 5 (5) | 3 (5) | 1 (6) | 0 | ||
MBL production | Low | 16 (15) | 8 (13) | 2 (11) | 1 (14) | |
Intermediate | 32 (31) | 20 (31) | 9 (50) | 1 (14) | ||
High | 57 (54) | 36 (56) | 7 (39) | 5 (71) |
*Cases include 16 patients with missing/unknown or other race. Per common designation, for MBL2, A refers to the wild-type structural allele, O refers to any of the 3 variant structural alleles, and O/O refers to any combination of structural variant alleles. Low producers included truncated haplotypes O/O and XA/O. MBL2, mannose-binding lectin gene.
†p<0.01 by Fisher exact test of difference in proportion across racial group.
1Portions of this study were presented at the Options for the Control of Influenza VII meeting, September 3–7, 2010, Hong Kong.
Page created: December 01, 2011
Page updated: December 01, 2011
Page reviewed: December 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.